Anti-hepatitis B activities of ganoderic acid from Ganoderma Lucidum
Biotechnology Letters 2006 Jun; 28(11):837-41 Epub 2006 May 31
Anti-hepatitis B activities of ganoderic acid from Ganoderma Lucidum
College of Life Science, South China Normal University, Guangzhou, P.R. Chi
Ganoderic acid, from Ganoderma lucidum, at 8 µg/ml inhibited replication of hepatitis B virus (HBV) in HepG2215 cells over 8 days. Production of HBV surface antigen and HBV e antigen were 20 and 44% of controls without ganoderic acid. Male KM mice were significantly protected from liver injury, induced with carbon tetrachloride, by treatment with ganoderic acid at 10 mg and 30 mg/kg•d (by intravenous injection) 7 days. Ganoderic acid at the same dosage also significantly protected the mice from liver injury induced by M. bovis BCG plus lipopolysaccharide (from Escherichia coli 0127:B8).
PMID: 16786250 [PubMed – indexed for MEDLINE]
Diagnosis: Breast cancer.
In January 2007 she noticed a nut sized lump, which quickly ulcerated to... Read More
Diagnosis: Colon cancer.
In September 2007 the doctors found a tumor-like lump on her right breast... Read More
Diagnosis: Colon cancer and Diabetes Mellitus.
This patient was diagnosed with colon cancer at the beginning of May 2008... Read More
Diagnosis: Colon cancer with metastasis on the liver.
Around the middle of November 2007 this patient noticed his stool was pink... Read More